Amgen, Inc. AMGN announced the launch of its Enbrel Mini with AutoTouch, a new auto injector device for Enbrel in the United States. The Enbrel Mini single-dose prefilled cartridges, used with the ...

The list prices of Stelara and Enbrel for Medicare users will be discounted nearly 70% come 2026 as a result of the first round CMS price negotiations with drugmakers, the White House has ...

Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...

The drug, called Enbrel, costs insurers an average of $46,772 per patient per year, according to 2022 data from the state’s all-payer claims database. The state board evaluated two other drugs ...

Sandoz (OTCQX:SDZXF), which was spun out of Swiss pharma giant Novartis (NVS) (OTCPK:NVSEF) in 2023, has developed an FDA-approved biosimilar version of Enbrel called Erelzi, and its lawsuit comes ...

In 2024, Enbrel generated $3.3 billion in revenue in the US. Sandoz received US FDA approval for Erelzi in 2016, the same year the company launched the medicine in Europe.

Last week, Colorado’s board declared that Enbrel, which costs more than $46,000 per year per patient, per the state’s claims database, is unaffordable for Colorado patients.

By last year, those Enbrel sales had shrunk to $690 million. In the lawsuit, Sandoz said that within a year of Erelzi’s launch in Europe, the price of Enbrel had declined by 50% and biosimilars ...